Cyclosporine in the treatment of cutaneous T cell lymphoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2273106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present our observations on the use of cyclosporine in the treatment of three patients with mycosis fungoides and two patients with Sézary syndrome. The patients with mycosis fungoides showed mild improvement of short duration. One patient with Sézary syndrome had significant improvement during 2 years of treatment. It is unlikely that cyclosporine alone will be sufficient therapy for cutaneous T cell lymphoma. However, lower doses in conjunction with other immunomodulators may minimize potential side effects and lead to longer lasting clinical improvement.
Medical subject headings
- Cyclosporins
- Mycosis Fungoides
- Sezary Syndrome
- Skin Neoplasms